Hannes Snellman counsel to Recipharm in the acquisition of OnTarget Chemistry
Recipharm acquires OnTarget Chemistry and extends its offering into preclinical development services. Recipharm has completed the acquisition of OnTarget Chemistry in Uppsala, Sweden. OnTarget Chemistry is a fast growing CRO company specialized in medicinal chemistry offering synthesis and analytical services which include rare and demanding specialties. 50% of the purchase price was paid in cash and the remaining 50% was paid through an issue in kind of 45.838 series B shares in Recipharm.